Related references
Note: Only part of the references are listed.Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study
Daniel J. Wallace et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Functional Evaluation of Activation-dependent Alterations in the Sialoglycan Composition of T Cells
Yuko Naito-Matsui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The Ligand-Binding Domain of Siglec-G Is Crucial for Its Selective Inhibitory Function on B1 Cells
Stefan Hutzler et al.
JOURNAL OF IMMUNOLOGY (2014)
Siglec-G Deficiency Leads to More Severe Collagen-Induced Arthritis and Earlier Onset of Lupus-like Symptoms in MRL/lpr Mice
Susanne Boekers et al.
JOURNAL OF IMMUNOLOGY (2014)
C-4 Modified Sialosides Enhance Binding to Siglec-2 (CD22): Towards Potent Siglec Inhibitors for Immunoglycotherapy
Sorge Kelm et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
CD22 ligation inhibits downstream B cell receptor signaling and Ca2+flux upon activation
N. Sieger et al.
ARTHRITIS AND RHEUMATISM (2013)
Genetic susceptibility to SLE: Recent progress from GWAS
Yong Cui et al.
JOURNAL OF AUTOIMMUNITY (2013)
Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis
Matthew S. Macauley et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Copresentation of Antigen and Ligands of Siglec-G Induces B Cell Tolerance Independent of CD22
Fabian Pfrengle et al.
JOURNAL OF IMMUNOLOGY (2013)
CD22 Is Required for Protection against West Nile Virus Infection
Daphne Y. Ma et al.
JOURNAL OF VIROLOGY (2013)
Suppressing the Antibody Response with Siglec Ligands
Lars Nitschke
NEW ENGLAND JOURNAL OF MEDICINE (2013)
CD22 ligand-binding and signaling domains reciprocally regulate B-cell Ca2+ signaling
Jennifer Mueller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
CD22 serves as a receptor for soluble IgM
Takahiro Adachi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
The Pan-B Cell Marker CD22 Is Expressed on Gastrointestinal Eosinophils and Negatively Regulates Tissue Eosinophilia
Ting Wen et al.
JOURNAL OF IMMUNOLOGY (2012)
CD22-Antagonists with nanomolar potency: The synergistic effect of hydrophobic groups at C-2 and C-9 of sialic acid scaffold
Hajjaj H. M. Abdu-Allah et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
The human Cas1 protein: A sialic acid-specific O-acetyltransferase?
Sigrid Arming et al.
GLYCOBIOLOGY (2011)
CD22 Is a Recycling Receptor That Can Shuttle Cargo between the Cell Surface and Endosomal Compartments of B Cells
Mary K. O'Reilly et al.
JOURNAL OF IMMUNOLOGY (2011)
CD22 Regulates Adaptive and Innate Immune Responses of B Cells
Norihito Kawasaki et al.
JOURNAL OF INNATE IMMUNITY (2011)
Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction
Guo-Yun Chen et al.
NATURE BIOTECHNOLOGY (2011)
The double life of a B-1 cell: self-reactivity selects for protective effector functions
Nicole Baumgarth
NATURE REVIEWS IMMUNOLOGY (2011)
In vivo targeting of B-cell lymphoma with glycan ligands of CD22
Weihsu C. Chen et al.
BLOOD (2010)
Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo
Bao Hoa Duong et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
CD22 x Siglec-G Double-Deficient Mice Have Massively Increased B1 Cell Numbers and Develop Systemic Autoimmunity
Julia Jellusova et al.
JOURNAL OF IMMUNOLOGY (2010)
Siglec-G Regulates B1 Cell Survival and Selection
Julia Jellusova et al.
JOURNAL OF IMMUNOLOGY (2010)
In Situ trans Ligands of CD22 Identified by Glycan-Protein Photocross-linking-enabled Proteomics
T. N. C. Ramya et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Functionally defective germline variants of sialic acid acetylesterase in autoimmunity
Ira Surolia et al.
NATURE (2010)
Potent small molecule mouse CD22-inhibitors: Exploring the interaction of the residue at C-2 of sialic acid scaffold
Hajjaj H. M. Abdu-Allah et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions
Lars Nitschke
IMMUNOLOGICAL REVIEWS (2009)
B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase
Annaiah Cariappa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Siglec-E Is Up-Regulated and Phosphorylated Following Lipopolysaccharide Stimulation in Order to Limit TLR-Driven Cytokine Production
Caroline R. Boyd et al.
JOURNAL OF IMMUNOLOGY (2009)
Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies
Isaac T. W. Harley et al.
NATURE REVIEWS GENETICS (2009)
CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses
Guo-Yun Chen et al.
SCIENCE (2009)
Characterization of mouse sialyltransferase genes: Their evolution and diversity
Shou Takashima
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2008)
CD22 regulates time course of both B cell division and antibody response
Taishi Onodera et al.
JOURNAL OF IMMUNOLOGY (2008)
Human B-lymphocytes express α2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2
Naoko Kimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation
Jonathan A. Deane et al.
IMMUNITY (2007)
Siglecg Limits the Size of B1a B Cell Lineage by Down-Regulating NFκB Activation
Cheng Ding et al.
PLOS ONE (2007)
Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population
Anja Hoffmann et al.
NATURE IMMUNOLOGY (2007)
Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignancies
J. P. Leonard et al.
ONCOGENE (2007)
Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation
Yuko Naito et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Siglecs and their roles in the immune system
Paul R. Crocker et al.
NATURE REVIEWS IMMUNOLOGY (2007)
High-affinity ligand probes of CD22 overcome the threshold set by cis ligands for binding, endocytosis, and killing of B cells
Brian E. Collins et al.
JOURNAL OF IMMUNOLOGY (2006)
ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling
Prabhjit K. Grewal et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Regulation of B cell development and B cell signalling by CD22 and its ligands α2,6-linked sialic acids
S Ghosh et al.
INTERNATIONAL IMMUNOLOGY (2006)
Siglec-H is an IPC-specific receptor that modulates type IIFN secretion through DAP12
AL Blasius et al.
BLOOD (2006)
Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling
BE Collins et al.
NATURE IMMUNOLOGY (2006)
Expression of aberrant forms of CD22 on B lymphocytes in Cd22(a) lupus-prone mice affects ligand binding
L Nitschke et al.
INTERNATIONAL IMMUNOLOGY (2006)
Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-Cell malignancies
RJ Kreitman et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking
S Han et al.
NATURE CHEMICAL BIOLOGY (2005)
Efficient killing of CD22+ tumor cells by a humanized diabody-RNase fusion protein
J Krauss et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact
BE Collins et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Printed covalent glycan array for ligand profiling of diverse glycan binding proteins
O Blixt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis
M Zhang et al.
GLYCOBIOLOGY (2004)
CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms
JC Poe et al.
NATURE IMMUNOLOGY (2004)
B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signaling
J Gerlach et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Normal β-1a cell development requires B cell-intrinsic NFATc1 activity
R Berland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Predominant autoantibody production by early human B cell precursors
H Wardemann et al.
SCIENCE (2003)
Activation of autoreactive B cells by CpG dsDNA
GA Viglianti et al.
IMMUNITY (2003)
The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound
S Kelm et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33
G Whitney et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
CD22 regulates B cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1
KL Otipoby et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Dysregulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22a lupus-prone mice
C Mary et al.
JOURNAL OF IMMUNOLOGY (2000)
CD22 forms a quaternary complex with SHIP, Grb2, and Shc - A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux
JC Poe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
